Tag: medullary thyroid carcinoma

Drug-adapted RET mutations

Written by
The active RET protein has been seen in many types of thyroid cancers.

RET is a protein tyrosine kinase that is upregulated and activated in many diverse forms of cancer. Treatments using RET-specific inhibitors have been highly effective, but the threat of resistance to these drugs looms. For this reason, Dr Jie Wu and Dr Blaine Mooers from the University of Oklahoma, together with Dr Vivek Subbiah from the University of Texas, decided […]

Read More… from Drug-adapted RET mutations